KLP Kapitalforvaltning’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$554K Hold
5,800
﹤0.01% 1470
2026
Q1
$558K Buy
5,800
+4,000
+222% +$400K ﹤0.01% 1379
2025
Q4
$175K Sell
1,800
-300
-14% -$25.7K ﹤0.01% 1885
2025
Q3
$149K Sell
2,100
-9,500
-82% -$633K ﹤0.01% 1923
2025
Q2
$694K Sell
11,600
-5,200
-31% -$285K ﹤0.01% 1177
2025
Q1
$882K Hold
16,800
﹤0.01% 998
2024
Q4
$924K Buy
+16,800
New +$884K ﹤0.01% 1032

Other funds holding IRMD

KLP Kapitalforvaltning's IRMD Position: Q2 2026 in Review

KLP Kapitalforvaltning held its iRadimed (IRMD) position steady in Q2 2026 at 5,800 shares worth $554K. The position accounts for ﹤0.01% of the portfolio, ranked #1470.

KLP Kapitalforvaltning first reported a position in IRMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $924K in Q4 2024. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • KLP Kapitalforvaltning held 5,800 shares of iRadimed worth $554K as of Q2 2026.
  • KLP Kapitalforvaltning left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1470 holding.
  • KLP Kapitalforvaltning first reported a position in iRadimed in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's iRadimed position peaked at $924K in Q4 2024.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.